InVirtuoLabs

Revolutionizing drug discovery with AI and physics-based methods

Problem

Traditional drug discovery is extremely challenging, requiring an average of $2.4 billion and 12 years per drug with a success rate below 10% in clinical development. The pharmaceutical industry urgently needs innovative solutions to improve efficiency and reduce time and cost in developing life-saving medications.

Solution

InVirtuoLabs' revolutionary platform harnesses cutting-edge AI and physics-based simulations to transform drug development. By generating and evaluating billions of potential drug candidates, the platform identifies molecules with superior properties before significant investments in synthesis and testing, more than doubling success rates while substantially reducing both time and capital required.

Core technology

InVirtuoLabs' platform is powered by InVirtuoGEN, our proprietary next-generation chemical language model. This advanced AI system enables molecular property prediction, de novo molecule generation, and fragment-constrained design. This comprehensive approach transforms drug discovery by intelligently navigating chemical space to identify optimal therapeutic candidates.